Arcutis Biotherapeutics (ARQT) has priced its initial public offering of 9.375M common shares at $17.00 per share, for gross proceeds of ~$159.4M.
The shares are expected to begin trading today on the Nasdaq Global Select Market.
Closing date is February 4.
Underwriters’ over-allotment is an additional 1,406,250 shares.
https://seekingalpha.com/news/3536715-arcutis-biotherapeutics-prices-initial-public-offering
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.